From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
Flora Peyvandi, former President of ISTH, recently shared an encourgaing post on gene editing on X:
”Precision gene editing progresses, despite challenges: They may be the products of tomorrow, but today’s health systems do not easily support their price-tags and complex administration requirements.”
Read the full article here.
Genetic Disorders — The Untouchables, or Are They?
As precision gene-editing technologies—such as CRISPR, base editing, and prime editing—continue to advance, they hold transformative potential for treating genetic diseases once considered unmanageable.
From rare blood disorders to inherited blindness, these therapies represent a new frontier in medicine.
However, despite the scientific breakthroughs, real-world implementation remains a challenge.
High development costs, complex delivery methods, and the need for specialized infrastructure have created significant barriers for health systems worldwide.
Closing this gap will be essential for ensuring equitable access to the future of genomic medicine.
Learn more on new advancements in the field of medicine from Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action